Gilead CAR-T Cancer Therapy Capacity to Quadruple by 2026 Gilead CAR-T Cancer Therapy Capacity to Quadruple by 2026

Gilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026 due to improvements in the U.S. biotech ' s manufacturing processes, an...Reuters Health Information
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news